PA
RMD icon

Pineridge Advisors’s ResMed RMD Stock Holding History

Pineridge Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$37K Sell
135
-211
-61% -$57.6K 0.01% 121
2025
Q2 		$89.2K Sell
346
-201
-37% -$47.9K 0.03% 81
2025
Q1 		$123K Sell
547
-79
-13% -$18.4K 0.05% 65
2024
Q4 		$143K Sell
626
-384
-38% -$92.5K 0.05% 68
2024
Q3 		$247K Sell
1,010
-121
-11% -$27K 0.09% 54
2024
Q2 		$217K Sell
1,131
-90
-7% -$18.3K 0.07% 57
2024
Q1 		$242K Sell
1,221
-78
-6% -$14.3K 0.09% 49
2023
Q4 		$223K Buy
+1,299
New +$200K 0.07% 61

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Pineridge Advisors's RMD Position: Q3 2025 in Review

Pineridge Advisors reduced its ResMed (RMD) stake by 61% in Q3 2025, selling an estimated $57.6K and leaving 135 shares worth $37K. The position accounts for 0.01% of the portfolio, ranked #121.

Pineridge Advisors first reported a position in RMD in Q4 2023 and has held it in 8 quarters since. The position peaked at $247K in Q3 2024. 949 funds tracked by Wall St. Rank hold RMD as of Q3 2025.

  • Pineridge Advisors held 135 shares of ResMed worth $37K as of Q3 2025.
  • Pineridge Advisors sold 211 ResMed shares in Q3 2025, an estimated $57.6K.
  • ResMed made up 0.01% of Pineridge Advisors's portfolio in Q3 2025, its #121 holding.
  • Pineridge Advisors first reported a position in ResMed in Q4 2023 and has held it in 8 quarters since.
  • Pineridge Advisors's ResMed position peaked at $247K in Q3 2024.
  • 949 funds tracked by Wall St. Rank held ResMed as of Q3 2025.

Based on Pineridge Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.